Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

BGMA Welcomes The Preliminary Report Of The European Commission Sectoral Inquiry Into The Pharmaceutical Industry, UK

Main Category: Pharma Industry / Biotech Industry
Article Date: 01 Dec 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Welcoming DG Competition's preliminary report published, BGMA Director Warwick Smith said:

The report clearly shows that the so-called research based pharmaceutical sector devotes more resources to trying to prevent generic competition and marketing its products than it does to developing new medicines needed by patients.

It is the job of the originator sector to develop new treatments. They get 15 years or more of market monopoly for new products during which time they make a profit on their investment. Generic companies then provide competition which acts as an incentive on the originators to develop new medicines, and reduces the drugs bill for the NHS so that it can afford to pay for them.

We strongly support this system. During the recent discussions on the PPRS, the originators made much of the need to get new products to market. We support them in that too. But the European Commission's report shows that their commercial strategies are more about extending the life of the older products and preventing generic competition than reducing the NHS drugs bill and developing new medicines.

Originators must live up to their promises. That means shifting their resources from their ad agencies and their lawyers into the laboratories. If they don't, for all their arguments on the PPRS, the NHS will keep paying too much for branded medicines and patients won't get the new medicines they need.

Note

1. DG Competition Report

Antitrust: preliminary report on the pharmaceutical sector inquiry can be found here

2. About the BGMA

The BGMA is made up of 19 members of the generic manufacturing industry, who between them account for around 85% of the UK market by volume.

The Association represents the interests of United Kingdom-based manufacturers and suppliers of generic medicines and promotes the development of the generic medicines industry in the United Kingdom.

BGMA




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
24 Jun 2009
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe...


Strategies for Quitting Smoking
Strategies for Quitting Smoking

Changing habits built up around smoking, as well as having a strategy to deal with cravings and the addiction to nicotine, can increase your chances of quitting smoking for good.

more videos are available in our health videos section.